dioscin has been researched along with Pancreatic Neoplasms in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Gao, S; Hao, J; Ren, H; Zhao, X | 1 |
| Han, X; Liu, K; Peng, J; Qi, Y; Si, L; Xu, L; Xu, Y; Yin, L; Zhao, Y | 1 |
2 other study(ies) available for dioscin and Pancreatic Neoplasms
| Article | Year |
|---|---|
[Effects of dioscin on apoptosis in pancreatic cancer MiaPaCa-2 cells and its mechanism].
Topics: Apoptosis; Diosgenin; Humans; Pancreatic Neoplasms; Peroxiredoxins; Reactive Oxygen Species | 2014 |
Potent effects of dioscin against pancreatic cancer via miR-149-3P-mediated inhibition of the Akt1 signalling pathway.
Topics: Animals; Antineoplastic Agents; Apoptosis; Cell Proliferation; Diosgenin; Dose-Response Relationship, Drug; Drug Screening Assays, Antitumor; Fluorescent Dyes; Humans; Mice; Mice, Inbred BALB C; Mice, Nude; MicroRNAs; Neoplasms, Experimental; Pancreatic Neoplasms; Proto-Oncogene Proteins c-akt; Signal Transduction; Structure-Activity Relationship; Tumor Cells, Cultured | 2017 |